drugset / Trial / NCT00955786
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This phase 1 study of CX-3543 is designed to test the safety, tolerability and highest safe dose level of this drug in patients with advanced solid tumor cancers.
Timeline
- Start
- 2005-07
- Primary completion
- 2007-07
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quarfloxin | Small molecule | — | Intravenous |